They showed notable activity against protein tyrosine phosphatase 1B (PTP1B), and since PTP1B is a promising drug target for type II diabetes and obesity, compounds 354 and 355 may contribute to the treatment of type II diabetes and obesity [109]. Here, PTPN1 is linked to type 2 diabetes mellitus.